Devices and kits for immunological analysis

• US 5,486,452 A
• Filed: 04/10/1987
• Issued: 01/23/1996
• Est. Priority Date: 04/29/1981
• Status: Expired due to Term

• Current Assignee: Novartis Corporation (Novartis Ag)
• Original Assignee: Ciba-Geigy Corporation (Novartis Ag)
• Inventors: Gordon, Julian, Hawkes, Richard, Niday, Evelyn, Towbin, Harry
• Primary Examiner(s): SAUNDERS, DAVID A
• Application Number:
  US07/038,470
• Time in Patent Office: 3,210 Days
• Field of Search: 436/506, 436/507, 436/509, 436/518, 436/530, 436/807, 436/821, 436/810, 435/7.1-7.23, 435/7.31, 435/7.32, 435/7.7, 435/7.72, 435/7.9-7.95, 435/970, 435/975
• US Class Current: 435/5
• CPC Class Codes: G01N 33/54386 Analytical elements
• CPC Class Codes: G01N 33/54393 Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
• CPC Class Codes: Y10S 435/97 Test strip or test slide
• CPC Class Codes: Y10S 435/975 Kit
• CPC Class Codes: Y10S 436/807 Apparatus included in process claim, e.g. physical support structures
• CPC Class Codes: Y10S 436/821 involving complement factors or complement systems

Abstract

New devices and kits for solid-phase immuno-assays comprising a solid porous support, preferably in the form of a sheet, where antigens or immuno-globulins or both of them are bound by direct application in any suitable geometry, e.g. as an assay of dots or lines. Such porous supports are suitable for effecting an unlimited number of antibody-antigen reactions simultaneously and in one operation.

Claims

1. An immunological analysis device consisting of a porous sheet of nitrocellulose containing an array of preselected geometry of delimited absorption areas of at least one compound capable of specifically binding an antigen (antigen-reactive compound) which adheres tightly and does not spread out on the surface of said porous sheet, said array of preselected geometry being obtained in said porous sheet by applying liquid aliquots of said antigen-reactive compound to said porous sheet mechanically via direct contact, wherein residual absorption sited in said porous sheet are unsaturated or saturated by non-specific protein.

2. The device of claim 1 wherein said antigen-reactive compound is an immunoglobulin of human or animal origin or a binding fragment thereof for the detection and quantitation of rheumatoid factor.

3. The device of claim 1 wherein said antigen-reactive compound is a complement protein for the detection and quantitation of a circulating immune complex which circulating immune complex comprises an antigen-antibody complex.

4. The device of claim 1 wherein said porous sheet is from about 0.01 to about 0.5 mm thick.

5. The device of claim 4 wherein said porous sheet is about 0.1 mm thick.

6. The device of claim 1 wherein said nitrocellulose has about 3 nitric acid groups per 6 carbon atoms.

7. The device of claim 1 wherein said porous sheet has an average pore size of about 0.45 um.

8. The device of claim 1 wherein said array is an array of dots.

9. The device of claim 1 wherein said array is an array of microdots having diameters less than 2 mm.

10. The device of claim 1 wherein said array is an array of lines of width of 2 mm or less.

11. The device of claim 1 wherein said antigen-reactive compound is applied to said support by a capillary tube, pipette, syringe, or spray.

12. The device of claim 1 wherein said antigen-reactive compound is applied to said support in volumes of less than 1 ul.

13. The device of claim 1 wherein said residual adsorption area is saturated with a serum containing substance, wherein said substance is undiluted total serum or total serum diluted with sodium chloride.

14. The device of claim 1 wherein said antigen-reactive compound is reactive to an antigen, wherein said antigen is a constituent of human biopsy material, mammalian tissue, mammalian cells, body fluids, fungi, protozoa, metazoan parasites, bacteria, mycoplasma, or viruses.

15. A kit comprising the device of claim 1 and reagents of an indicator system in pre-aliquoted or dessicated form to allow detection of an antigen -- antigen reactive compound complex.

16. The kit of claim 15 wherein said indicator is selected from the group consisting of

A) antibodies capable of forming antigen-antibody complexes, wherein the antibody is radioactively labelled, conjugated with a fluorescent substance or conjugated with an enzyme capable of giving a color reaction with a suitable substrate,

B) complement protein capable of binding to antigen-antibody complexes, wherein the complement protein is radioactively labelled, conjugated with a fluorescent substance or conjugated with an enzyme capable of giving color reaction with a suitable substrate, and

C) complement protein and a further specific anti-complement antibody, wherein the antibody is radioactively labelled, conjugated with a fluorescent substance or conjugated with an enzyme capable of giving a color reaction with a suitable substrate.

17. The kit of claim 16, wherein said antigen-reactive compound is complement protein for the detection and quantitation of circulating immune complex which circulating immune complex comprises an antigen-antibody complex and wherein the indicator is a group A) antibody radioactively labelled, conjugated with a fluorescent substance or conjugated with an enzyme capable of giving a color reaction with a suitable substrate.

18. The kit of claim 15, wherein said antigen-reactive compound is an immunoglobulin of human or animal origin or a binding fragment thereof for the detection and quantitation of rheumatoid factor.

19. The kit of claim 15, comprising a multi-cavity plastic tray, lyophilized mixtures of indicator antibody, salts, buffers, carrier serum or protein, and pre-determined amounts of indicator enzyme chromogenie substrate, salts, buffers, and ampoules containing pre-measured volumes of liquid substrates, all in suitable packaging.

20. The kit of claim 15 wherein said reagents of said indicator system comprise a substrate, a cofaetor or prosthetic group for an indicator enzyme, or a coupled series of enzymes.

21. The kit of claim 15, wherein the reagents of said indicator system comprise a covalent adduct between an antigen and a signalling molecule.

22. A method of immunological analysis comprising

(a) incubating the device of claim 1 wherein residual absorption sites in said porous sheet are saturated by non-specific protein, with a sample containing an immunoglobulin or other antigen to be detected;

(b) incubating said device with a solution of an indicator selected from the group consisting of

A) antibodies capable of forming antigen-antibody complexes, wherein the antibody is radioactively labelled, conjugated with a fluorescent substance or conjugated with an enzyme capable of giving a color reaction with a suitable substrate,

B) complement protein capable of binding to antigen-antibody complexes, wherein the complement protein is radioactively labelled, conjugated with a fluorescent substance or conjugated with an enzyme capable of giving color reaction with a suitable substrate, and

C) complement protein and a further specific anti-complement antibody, wherein the antibody is radioactively labelled, conjugated with a fluorescent substance or conjugated with an enzyme capable of giving a color reaction with a suitable substrate;

(c) when the antibody or complement protein of step (b) is conjugated with an enzyme, incubating said device with a solution of said suitable enzyme substrate; and

(d) detecting the signal of said indicator of step (b).

23. The method of claim 22, wherein the incubation with a sample containing the immunogloblin or antigen to be detected is in the presence of non-specific proteins with regard to the immunoreactive compounds.

24. The method of claim 22, wherein the indicator is selected from the group consisting of radioactively labelled antibodies, antibodies conjugated with a fluorescent substance, and antibodies conjugated with an enzyme capable of giving a color reaction with a suitable substrate.

25. A method of claim 22, wherein the indicator is a horseradish peroxidase conjugated antibody.

26. An immunological analysis device consisting of a porous sheet of nitrocellulose containing an array of preselected geometry of delimited absorption areas of at least one antigen, which adheres tightly and does not spread out on the surface of said porous sheet, said array of preselected geometry being obtained in said porous sheet by applying liquid aliquots of said antigen to said porous sheet mechanically via direct contact, wherein residual absorption sites in said porous sheet are unsaturated or saturated by non-specific protein.

27. The device of claim 26 wherein said porous sheet is from about 0.01 to about 0.5 mm thick.

28. The device of claim 27 wherein said porous sheet is about 0.1 mm thick.

29. The device of claim 27 wherein said nitrocellulose has about 3 nitric acid groups per 6 carbon atoms.

30. The device of claim 27 wherein said porous sheet has an average pore size of about 0.45 um.

31. The device of claim 27 wherein said array is an array of dots.

32. The device of claim 27 wherein said array is an array of microdots having diameters less than 2 mm.

33. The device of claim 27 wherein said array is an array of lines of width of 2 mm or less.

34. The device of claim 26 wherein said antigen is applied to said support by a capillary tube, pipette, syringe, or spray.

35. The device of claim 26 wherein said antigen is applied to said support in volumes of less than 1 ul.

36. The device of claim 26 wherein said residual adsorption area is saturated with a serum containing substance, wherein said substance is undiluted total serum a total serum diluted with sodium chloride.

37. The device of claim 26 wherein said antigen is a constituent of human biopsy material, mammalian tissue, mammalian cells, body fluids, fungi, protozoa, metazoan parasites, bacteria, mycoplasma, or viruses.

38. A kit comprising the device of claim 26 and reagents of an indicator system in pre-aliquoted or dessicated form to allow detection of an antigen -- antigen reactive compound complex.

39. The kit of claim 38 wherein said indicator is selected from the group consisting

A) antibodies capable of forming antigen-antibody complexes, wherein the antibody is radioactively labelled, conjugated with a fluorescent substance or conjugated with an enzyme capable of giving a color reaction with a suitable substrate,

B) complement protein capable of binding to antigen-antibody complexes, wherein the complement protein is radioactively labelled, conjugated with a fluorescent substance or conjugated with an enzyme capable of giving color reaction with a suitable substrate, and

C) complement protein and a further specific anti-complement antibody, wherein the antibody is radioactively labelled, conjugated with a fluorescent substance or conjugated with an enzyme capable of giving a color reaction with a suitable substrate.

40. The kit of claim 38, comprising a multi-cavity plastic tray, lyophilized mixtures of indicator antibody, salts, buffers, carrier serum or protein, and pre-determined amounts of indicator enzyme chromogenic substrate, salts, buffers, and ampoules containing pre-measured volumes of liquid substrates, all in suitable packaging.

41. The kit of claim 38 wherein said reagents of said indicator system comprise a substrate, a cofactor or prosthetic group for an indicator enzyme, or a coupled series of enzymes.

42. The kit of claim 38, wherein the reagents of said indicator system comprise a covalent adduct between an antigen and a signalling molecule.

43. A method of immunological analysis comprising (a) incubating the device of claim 26 wherein residual absorption sites in said porous sheet are saturated by non-specific protein, with a sample containing an immunoglobulin to be detected;

(b) incubating said device with a solution of an indicator selected from the group consisting of

A) antibodies capable of forming antigen-antibody complexes, wherein the antibody is radioactively labelled, conjugated with a fluorescent substance or conjugated with an enzyme capable of giving a color reaction with a suitable substrate,

B) complement protein capable of binding to antigen-antibody complexes, wherein the complement protein is radioactively labelled, conjugated with a fluorescent substance or conjugated with an enzyme capable of giving color reaction with a suitable substrate, and

C) complement protein and a further specific anti-complement antibody, wherein the antibody is radioactively labelled, conjugated with a fluorescent substance or conjugated with an enzyme capable of giving a color reaction with a suitable substrate;

(c) when the antibody or complement protein of step (b) is conjugated with an enzyme, incubating said device with a solution of said suitable enzyme substrate; and

(d) detecting the signal of said indicator of step (b).

44. The method of claim 43, wherein the incubation with a sample containing the immunogloblin to be detected is in the presence of non-specific proteins with regard to the immunoreactive compounds.

45. The method of claim 43, wherein the indicator is selected from the group consisting of radioactively labelled antibodies, antibodies conjugated with a fluorescent substance, and antibodies conjugated with an enzyme capable of giving a color reaction with a suitable substrate.

46. A method of claim 43, wherein the indicator is a horseradish peroxidase conjugated antibody.

47. A method of producing an immunoassay device which comprises the steps of:

(a) applying droplets of substantially enriched aqueous solutions of antibodies of distinct specification to a substantially planar surface of a support, locating said droplets so that they cover small, discrete, closely spaced areas of the planar surface of the support and form an array;

(b) allowing said aqueous solutions of antibodies to remain on said areas of the surface for a period of time long enough for the antibodies in solution to be adsorbed to said areas of the surface to form discrete, antibody-coated areas;

(c) swiftly flooding the entire surface of the solid support with an aqueous solution of protein in order to block non-specific binding sites in areas of the surface of the solid support which surround the antibody-coated areas; and

(d) washing and drying the device.